Context-dependent roles of B cells during intestinal helminth infection

PLoS Negl Trop Dis. 2021 May 13;15(5):e0009340. doi: 10.1371/journal.pntd.0009340. eCollection 2021 May.

Abstract

The current approaches to reduce the burden of chronic helminth infections in endemic areas are adequate sanitation and periodic administration of deworming drugs. Yet, resistance against some deworming drugs and reinfection can still rapidly occur even after treatment. A vaccine against helminths would be an effective solution at preventing reinfection. However, vaccines against helminth parasites have yet to be successfully developed. While T helper cells and innate lymphoid cells have been established as important components of the protective type 2 response, the roles of B cells and antibodies remain the most controversial. Here, we review the roles of B cells during intestinal helminth infection. We discuss the potential factors that contribute to the context-specific roles for B cells in protection against diverse intestinal helminth parasite species, using evidence from well-defined murine model systems. Understanding the precise roles of B cells during resistance and susceptibility to helminth infection may offer a new perspective of type 2 protective immunity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anthelmintics / therapeutic use
  • Antibodies, Helminth / immunology*
  • B-Lymphocytes / immunology*
  • Germinal Center / immunology
  • Helminthiasis / drug therapy
  • Helminthiasis / immunology*
  • Helminthiasis / parasitology
  • Helminths / drug effects
  • Helminths / immunology*
  • Humans
  • Intestinal Diseases, Parasitic / drug therapy
  • Intestinal Diseases, Parasitic / immunology*
  • Intestinal Diseases, Parasitic / parasitology
  • Mice
  • Protozoan Vaccines / immunology
  • Reinfection / parasitology
  • Reinfection / prevention & control
  • T-Lymphocytes, Helper-Inducer / immunology

Substances

  • Anthelmintics
  • Antibodies, Helminth
  • Protozoan Vaccines

Supplementary concepts

  • Intestinal helminthiasis

Grants and funding

This work was supported by grants from the National Health and Medical Research Council of Australia (APP1104433 and APP1104466 to C.Z.), a Viertel-Belberry Senior Medical Research Fellowship (to K.L.G.-J.) and a Monash University Biomedicine Discovery Scholarship (to A.Z.). Salaries of A.Z. (Monash University) and K.L.G.-J. (Viertel-Belberry) were partially covered by funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.